DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™
TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence healthcare company, provides a development and commercialization update for CERVAI™, a brain health AI platform.
- TORONTO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative artificial intelligence healthcare company, provides a development and commercialization update for CERVAI™, a brain health AI platform.
- A world first, CERVAI™ consists of a Brain Age Estimation and Brain Health Assessment tool.
- The Brain Health Assessment tool generates clinician-observed measures and a brain health score.
- Fabio Chianelli, Chairman and CEO of DiagnaMed, commented: “We are in the final stage of development for CERVAI™, our novel brain health AI platform.